How Much Can Roche's Share Price Grow If Ocrevus Doubles Its Share In Multiple Sclerosis Market?

Roche Holding's (NASDAQ:RHHBY) Ocrevus has been on a stellar run with sales exceeding $2.4 billion in 2018, reflecting a growth of 2.8x over the prior year. This can be attributed to its high efficacy and modest pricing. The drug's peak sales are estimated to be north of $4 billion. The drug is ...